Evidence map›Paper›PMID 32806100›Full record

ArticleThe Journal of organic chemistry2020

Visible Light-Mediated Photochemical Reactions of 2-(2'-Alkenyloxy)cycloalk-2-enones.

Raphaela Graßl, Christian Jandl, Thorsten Bach

Abstract read
In one paragraph

Article in The Journal of organic chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Raphaela GraßlDepartment Chemie and Catalysis Research Center (CRC), Technische Universität München, Lichtenbergstr. 4, 85747 Garching, Germany.
Christian JandlDepartment Chemie and Catalysis Research Center (CRC), Technische Universität München, Lichtenbergstr. 4, 85747 Garching, Germany.
Thorsten BachDepartment Chemie and Catalysis Research Center (CRC), Technische Universität München, Lichtenbergstr. 4, 85747 Garching, Germany.ORCID http://orcid.org/0000-0002-1342-0202

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The title compounds were prepared, and their reactivity was studied upon sensitized irradiation at λ = 420 nm. Thioxanthen-9-one was employed as the sensitizer at a loading of 10 mol % in small-scale reactions and of 2.5 mol % on a larger scale. Cyclohex-2-enones substituted by a 2'-propenyloxy, 2'-butenyloxy, 2'-pentenyloxy, or 2'-methyl-2'-propenyloxy group in the 2-position gave the products of an intramolecular [2 + 2] photocycloadditon. The reaction proceeded with high regioselectivity (crossed product) and perfect diastereoselectivity (nine examples, 34-99% yield). If the olefin in the tether was trisubstituted (3'-methyl-2'-butenyloxy), no cycloaddition was observed. Rather, a cyclization with subsequent hydrogen abstraction occurred (three examples, 65-86% yield). The results are consistent with a reaction course via a triplet enone intermediate and the formation of a 1,4-diradical by an initial cyclization. The analogous cyclopent-2-enones were less prone to an intramolecular reaction. Instead, decomposition or intermolecular [2 + 2] photocycloaddition reactions prevailed. In the latter event, two main products were identified (three examples, 30-43% yield), resulting either from a head-to-head [2 + 2]-photodimerization or from a twofold [2 + 2] photocycloaddition of the enone to the olefin. The latter reaction sequence generated pentacyclic products with a central [1,5]dioxocane ring. The structure assignment of the two product types was corroborated by a single-crystal X-ray analysis.

Identifiers

PMID32806100
PMCPMC7476038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.